Posted inWorkforce & Jobs of the FuturePhilly How urban planner Eli Epperson is building a life sciences pipeline for Philly teens Written by Sarah Huffman March 5, 2026March 5, 2026 Posted on
Posted inEntrepreneurship & BusinessMaryland Gilead to acquire Rockville-area cancer drug developer Arcellx in $8B deal Written by Maria Eberhart February 24, 2026February 24, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Johnson & Johnson to invest $1B in Montgomery County cell therapy manufacturing site Written by Sarah Huffman February 18, 2026February 18, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly ALS drug trial shows promising signs for Philly-area startup’s once-daily pill Written by Holly Quinn February 12, 2026February 11, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Genentech grants $300k to Science Center to bring biotech breakthroughs to market faster Written by Sarah Huffman February 6, 2026February 5, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Exit interview: Wistar exec Dario Altieri on how to take Philly life sciences to the next level Written by Sarah Huffman February 4, 2026February 3, 2026 Posted on
Posted inEntrepreneurship & BusinessPittsburgh Pitt debuts new $25M Trivedi Institute to turn space research into life science startups Written by Alice Crow February 3, 2026February 3, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Eli Lilly expands Southeast PA presence with $3.5B drug manufacturing facility Written by Sarah Huffman January 30, 2026January 30, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Philly-headquartered virtual biotech Cantai Therapeutics raises $3M Written by Sarah Huffman January 30, 2026January 29, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Ladder Bio enters 2026 with a new CEO, a rebrand and a fresh $5.5M seed round Written by Sarah Huffman January 16, 2026January 15, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Penn, BioNTech launch $50M fund to support early-stage life sciences startups Written by Sarah Huffman January 9, 2026January 9, 2026 Posted on
Posted inEntrepreneurship & BusinessPhilly Alveus Therapeutics exits stealth with $160M, developing an alternative to drugs like Ozempic Written by Sarah Huffman January 8, 2026January 9, 2026 Posted on